Q3 results are in and here are the highlights:
โ We're growing at unprecedented speed. PRE revenue up 568% YoY to $23.6M
- IM8: From $0 to $120M ARR in just 12 months - fastest supplement brand growth in industry history globally.
โ Clear path to scale. Projects $180-200M FY 2026 revenue, $25M monthly revenue and $300M ARR by end of 2026.
โ Global scale achieved rapidly. 420K+ customer purchases across 31 countries. 46.5% USA revenue and 56.5% international revenue demonstrates universal appeal of science-backed solutions.
โ Strong unit economics. 60% gross margins. 3.9-month customer payback period. 80% subscription rate. $150 AOV up 36% QoQ. Quality growth that compounds.
โ Strong balance sheet for aggressive scaling. $122M total liquidity ($82M cash + 387 BTC, valued at ~$40M Bitcoin). Zero debt. Financial strength to capture maximum market opportunity.
โ Dual-engine growth model. Health drives recurring revenue, wealth preserves value. Only NASDAQ consumer health company with Bitcoin treasury strategy, continuing 1 BTC purchase per day
- Building toward 2030 $1B annual revenue vision with proven fundamentals and capital to execute.
see my first shareholder letter here:
https://t.co/Xv6SsqlyL9
full press release here:
https://t.co/tJ334X8Iq8